Preventive Medicine News

New data show that female surgeons face significantly greater risks for infertility, pregnancy loss and complications, including a higher likelihood of musculoskeletal disorders, nonelective cesarean delivery and postpartum depression.

Medicare eligibility was associated with sharp reductions in racial and ethnic disparities in health insurance coverage, access to care and self-reported health, according to findings published in JAMA Internal Medicine.

The CDC recently updated its guidance to say that even vaccinated individuals should wear masks indoors when in areas with high or substantial COVID-19 transmission.

More than 1 in 4 men aged 55 to 69 years and 1 in 3 men aged 70 years and older underwent prostate cancer screening in the previous 12 months, “suggesting potential overuse among some men,” researchers reported.

Many transgender men and nonbinary people assigned female at birth, or TMNB, reported barriers to cervical cancer screening, according to results of a cross-sectional survey of these underserved populations.

Data showed that 1 year of romosozumab followed by a year of alendronate was associated with larger gains in bone mineral density at the lumbar spine than 2 years of alendronate alone in postmenopausal women with osteoporosis.

An analysis of DAPA-CKD data showed dapagliflozin reduces the risk for kidney failure and mortality in patients with advanced chronic kidney disease, a subgroup that made up 14% of the study population included in the initial trial.

Multitarget fecal immunochemical testing yielded better diagnostic accuracy in the detection of advanced adenomas compared with basic FIT, according to research published in Annals of Internal Medicine.

Increasing amounts of habitual coffee consumption were inversely linked with a lower risk for arrhythmia, according to a prospective cohort study of nearly 400,000 adults in the United Kingdom.

The SGLT2 inhibitor ertugliflozin shows promise for preserving kidney function in patients with type 2 diabetes and atherosclerotic cardiovascular disease, results of a placebo-controlled trial suggested.